Midterm #3: Signal Transduction Flashcards
1
Q
Intercellular vs. Intracellular Signal Transduction, Incoming Signals, Initial Receptors
A
- Intercellular Signal Transduction: a signal passes from one cell to another
- Intracellular Signal Transduction: the receiving cell biochemically decodes that signal
- Signals may include: gas (NO), amino acid (glutamate), steroid (estrogen), peptide hormone (insulin), protein (growth factors)
- The initial receptors: may exist on the surface of the cell (cell surface receptors) or within it (intracellular/nuclear receptors)
2
Q
Intracellular Communication Mechanisms: endocrine, paracrine, autocrine, juxtacrine, matricine
A
- Endocrine: specialized sender cells (glands) synthesized and secrete molecules (hormones) into the blood. All cells are exposed, but only those containing the appropriate receptors are affected
- Paracrine: Sender cells secretes molecules into the local environment only (local mediators)
- Autocrine: Sender cell secretes molecules into the local environment and receives them itself
- Juxtacrine: Cell-to-cell contact
- Matricine: cell to extracellular matrix
3
Q
Nuclear Receptors
A
- Hydrophobic Small Molecules
- Diffuse through plasma membrane and bind to intracellular receptors
- Transcription Factors
4
Q
Type 1 Nuclear Receptor
A
- bind to ligand in the cytoplasm
- homodimerize
- translocated into the nucleus (via nuclear pore complex)
- bind to transcription element
- initiate transcription
- Examples:
- sex hormone receptors
- glucocorticoid receptor
- mineralcorticoid receptor
5
Q
Type II Nuclear Receptor
A
- constituitively exist in the nucleus in DNA bound heterodimers
- Often bound to a corepressor protein
- Ligand binding triggers dissociation of the corepressor and association of a coactivator
- allows the recruitment of RNAP and initiation of transcription
- Examples:
- thyroid hormone receptor (TR)
- retinoic acid receptor (RAR)
- aryl hydrocarbon receptor (AhR)*
- pregnane X receptor (PXR)*
- constituitive androstane receptor (CAR)*
- *binds to xenotic response elements, important for CYP induction
6
Q
Cell Surface Receptors
A
- binds to ligands at the extracellular surface
- wide variety of ligands, small molecules, peptides and large proteins
- Receptor Tyrosine Kinase, G-Couple Protein Receptors
7
Q
Receptor Tyrosine Kinase (RTK) Family
A
- Bind growth factors and certain hormones
- cytokines
- Trigger intracellular phosphorylation cascades to cause effects
8
Q
G-Coupled Protein Receptors
A
- bind a wide variety of ligands
- intracellular second messanger to ellict their effects
9
Q
Receptor Tyrosine Kinase Mechanism
A
- Hormone binding extracellular domain activates cytosolic tyrosine kinase domain
- autophosphorylates specific Tyr residues and activates the receptor
- Activated receptor binds to and phosphorylates Tyr residues on specific target proteins, which are often kinase enzymes themselves
- Examples:
- insulin receptor
- EGFR (epidermal growth factor receptor)
- VEGFR (vascular endothelial growth factor receptor)
10
Q
EGFR as Therapeutic Target
A
- EGF binding to EGFR stimulates cell proliferation
- EGFR-targeting drugs include
-
monoclonal antibodies such as cetuximab (Erbitux)
- inhibit EGF binding
- small molecules like **erlotinib **(Tarceva)
- inhibit autophosphorylation and downstream signaling
-
monoclonal antibodies such as cetuximab (Erbitux)
11
Q
VEFGR as Therapeutic Target
A
- VEGF binds VEGFR and stimulates blood vessel growth (angiogenesis/vasculogenesis)
- Important in tumor growth and age-related macular degeneration
- Bevacizumab (Avastin) is approved for certain cancers and used off label to treat AMD
- **Ranibizumab **(Lucentis) is a fragment of the same mAb approved to specifically treat AMD
12
Q
What is this structure?
A
Erlotinib (Tarceva)
13
Q
G-Protein Coupled Receptors (aka 7TM Receptors) Mechanism
A
- 7 TM alpha helices bundled together
- Cause downstream effects through GTP-ases called G-proteins
- Resting state:
- GPCR associate with **heterotrimeric G-proteins **(alpha, beta, and gamma) with the Ga bound to GDP
- When ligands bind:
- Undergoes confirmational changes that causes Ga to release GDP and bind GTP
- Ga dissociates from Gbg with activates both complexes
- Complexes interact with downstream effectors (like adenylate cyclase and phospholipase C) to change second messanger levels
- Activation of G protein is short lived
- Ga slowly hydrolyzes GTP and Ga-GDP rebinds Gbg to reassemble the inactive heterotrimer
14
Q
cAMP second messanger signaling by GPCR
A
- Adenylate cyclase is a membrane bound protein that catalyzes the synthesis of cAMP
- Activated Ga subunits regulate the activity of adenylate cyclase: Gas stimulates and Gai inhibits
- cAMP regulates the activity of protein kinase A
- PKA is an inactive heterotetramer consisting of 2 regulatory and 2 catalytic subunits
- cAMP binds the regulatory subunits which release the active catalytic subunits
- Activated PKA subunits then phosphorylate Ser and Thr residues on target proteins
15
Q
cAMP Second Messanger Signaling in Muscle Cell
A
- epinephrine binds to alpha-adrenergic receptor and activates associated Gas
- This activates adenylate cyclase, which generates cAMP, which activates PKA
- PKA phosphorylates:
- glycogen synthase (inactivation)
- phosphorylase kinase (activation)
- Glycogen is broken down to glucose to power muscle
- PKA also phosphorylates ser and thr residues on the insulin receptor and decreases it’s catalytic activity